| 2D | two-dimensional |
| 3D | three-dimensional |
| 300 µM BR | 300 µM bioreactors |
| 1000 µM BR | 1000 µM bioreactors |
| A1AT | α-1-antitrypsin |
| ABCB1 | ATP-binding cassette B1 |
| ABCC2 | ATP-binding cassette C2 |
| ABCG2 | ATP-binding cassette G2 |
| ALB | albumin |
| ALT | alanine transaminase |
| ARG1 | arginase 1 |
| APOC1 | apolipoprotein C-I |
| ASL | argininosuccinate lyase |
| AST | aspartate transaminase |
| ATF3 | activating transcription factor 3 |
| B2M | β -2-microglobulin |
| BCRP | breast cancer resistance protein |
| CK 18 | cytokeratin 18 |
| control BR | control bioreactors |
| CPS1 | mitochondrial carbamoyl-phosphate synthase 1 |
| CYP | cytochrome P450 |
| DILI | drug-induced liver injury |
| DMSO | dimethyl sulfoxide |
| FDR | False Discovery Rate |
| GLDH | glutamate dehydrogenase |
| GDF15 | growth differentiation factor 15 |
| LDH | lactate dehydrogenase |
| MS | mass spectrometry |
| NRF2/KEAP1 | nuclear factor (erythroid-derived 2)-like 2/kelch-like ECH-associated protein 1 |
| OTC | ornithine transcarbamoylase |
| pHH | primary human hepatocytes |
| SEM | standard errors of the mean |
| TTR | transthyretin |
| UDP | uridine diphosphate |
| UGT2B7 | UDP glucuronosyltransferase 2B7 |